Quest Diagnostics Incorporated
DGX
주식 순위
#934
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
주가
$234.00
시가총액
$25.83B
변동 (1일)
-0.30%
변동 (1년)
23.48%
국가
US
거래 Quest Diagnostics Incorporated (DGX)
카테고리
Healthcare
Quest Diagnostics Incorporated (DGX)의 EPS
June 2026 기준 EPS TTM: $9.54
Quest Diagnostics Incorporated의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $9.54입니다. 2024년 말에는 회사의 EPS가 $7.80였으며, 이는 2023년의 EPS $7.59와 증가입니다.
Quest Diagnostics Incorporated의 EPS 기록 (2000 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $9.54 | 7.55% |
| 2025 | $8.87 | 13.72% |
| 2024 | $7.80 | 2.77% |
| 2023 | $7.59 | -6.53% |
| 2022 | $8.12 | -48.93% |
| 2021 | $15.90 | 48.88% |
| 2020 | $10.68 | 67.40% |
| 2019 | $6.38 | 17.93% |
| 2018 | $5.41 | -3.91% |
| 2017 | $5.63 | 22.93% |
| 2016 | $4.58 | -6.91% |
| 2015 | $4.92 | 28.46% |
| 2014 | $3.83 | -31.36% |
| 2013 | $5.58 | 59.89% |
| 2012 | $3.49 | 18.31% |
| 2011 | $2.95 | -27.70% |
| 2010 | $4.08 | 4.35% |
| 2009 | $3.91 | 30.77% |
| 2008 | $2.99 | 69.89% |
| 2007 | $1.76 | -40.94% |
| 2006 | $2.98 | 9.96% |
| 2005 | $2.71 | 10.61% |
| 2004 | $2.45 | 16.11% |
| 2003 | $2.11 | 26.35% |
| 2002 | $1.67 | 91.95% |
| 2001 | $0.87 | 52.63% |
| 2000 | $0.57 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $18.62 | 95.18% |
US
|
|
| $5.65 | -40.78% |
US
|
|
| $-1.36 | -114.26% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -46.65% |
US
|
